These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 29879072

  • 21. An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N, Mizutani KI, Kumagai M, Shioya A, Guo X, Nakada S, Fujimoto S, Kawabata H, Masaki Y, Takai K, Aoki S, Kojima M, Nakamura S, Kida M, Yamada S.
    Pathol Res Pract; 2019 Mar; 215(3):410-413. PubMed ID: 30642741
    [Abstract] [Full Text] [Related]

  • 22. Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute.
    Maida S, Nakagawa H, Ureshino H, Kajihara K, Yamazaki S, Ichinohe T.
    Blood Cells Mol Dis; 2024 Sep; 108():102870. PubMed ID: 38901333
    [Abstract] [Full Text] [Related]

  • 23. TAFRO Syndrome: A Disease Requiring Immediate Medical Attention.
    Masaki Y, Ueda Y, Yanagisawa H, Arita K, Sakai T, Yamada K, Mizuta S, Fukushima T, Takai K, Aoki S, Kawabata H.
    Intern Med; 2023 Jan 01; 62(1):27-32. PubMed ID: 35598998
    [Abstract] [Full Text] [Related]

  • 24. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H, Tanaka K, Fujiwara M, Iwasaki T, Numata T, Oda A, Kanno M, Tanaka M, Eiro M, Satoh M, Kazama JJ.
    CEN Case Rep; 2019 Nov 01; 8(4):239-245. PubMed ID: 31077056
    [Abstract] [Full Text] [Related]

  • 25. [TAFRO syndrome with primary Sjogren's syndrome].
    Iwanaga N, Harada K, Tsuji Y, Kawahara C, Kurohama K, Izumi Y, Yoshida S, Fujikawa K, Ito M, Kawakami A, Migita K.
    Nihon Rinsho Meneki Gakkai Kaishi; 2016 Nov 01; 39(5):478-484. PubMed ID: 27795506
    [Abstract] [Full Text] [Related]

  • 26. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
    Simeni Njonnou SR, Deuson J, Royer-Chardon C, Vandergheynst FA, Wilde V.
    BMJ Case Rep; 2020 Jun 30; 13(6):. PubMed ID: 32606113
    [Abstract] [Full Text] [Related]

  • 27. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
    Minomo S, Fujiwara Y, Sakashita S, Takamura A, Nagata K.
    J Med Case Rep; 2021 Jan 06; 15(1):3. PubMed ID: 33402219
    [Abstract] [Full Text] [Related]

  • 28. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y, Takahashi S, Nishi K, Sakamaki T, Mitani S, Kaneko H, Mizutani C, Ukyo N, Hirata H, Tsudo M.
    Tohoku J Exp Med; 2015 Aug 06; 236(4):289-95. PubMed ID: 26250536
    [Abstract] [Full Text] [Related]

  • 29. Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome.
    Tsurumi H, Fujigaki Y, Yamamoto T, Iino R, Taniguchi K, Nagura M, Arai S, Tamura Y, Ota T, Shibata S, Kondo F, Kurose N, Masaki Y, Uchida S.
    Intern Med; 2018 May 15; 57(10):1433-1438. PubMed ID: 29321413
    [Abstract] [Full Text] [Related]

  • 30. International definition of iMCD-TAFRO: future perspectives.
    Nishimura Y, Nishimura MF, Sato Y.
    J Clin Exp Hematop; 2022 Jun 28; 62(2):73-78. PubMed ID: 35474036
    [Abstract] [Full Text] [Related]

  • 31. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
    Srkalovic G, Marijanovic I, Srkalovic MB, Fajgenbaum DC.
    Bosn J Basic Med Sci; 2017 May 20; 17(2):81-84. PubMed ID: 28135567
    [Abstract] [Full Text] [Related]

  • 32. Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.
    Kikuchi T, Shimizu T, Toyama T, Abe R, Okamoto S.
    Intern Med; 2017 Aug 15; 56(16):2205-2211. PubMed ID: 28781319
    [Abstract] [Full Text] [Related]

  • 33. Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor: A case report.
    Kadoba K, Waki D, Nishimura K, Mukoyama H, Saito R, Murabe H, Yokota T.
    Medicine (Baltimore); 2020 Oct 16; 99(42):e22793. PubMed ID: 33080751
    [Abstract] [Full Text] [Related]

  • 34. Sjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.
    Fujimoto S, Kawabata H, Kurose N, Kawanami-Iwao H, Sakai T, Kawanami T, Fujita Y, Fukushima T, Masaki Y.
    Medicine (Baltimore); 2017 Dec 16; 96(50):e9220. PubMed ID: 29390349
    [Abstract] [Full Text] [Related]

  • 35. Treatment-resistant idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, renal dysfunction, and organomegaly managed with Janus kinase inhibitors: A case report.
    Kakutani T, Nunokawa T, Chinen N, Tamai Y.
    Medicine (Baltimore); 2022 Dec 02; 101(48):e32200. PubMed ID: 36482523
    [Abstract] [Full Text] [Related]

  • 36. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
    Nagayama Y, Yamano M, Yagame M, Nariyama T, Takahashi M, Kawamoto M, Matsui K.
    BMC Nephrol; 2019 Oct 17; 20(1):375. PubMed ID: 31623576
    [Abstract] [Full Text] [Related]

  • 37. TAFRO syndrome with a fatal clinical course following BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccination: A case report.
    Yamada M, Sada RM, Kashihara E, Okubo G, Matsushita S, Manabe A, Tagawa S, Akebo H, Miyake H, Hatta K.
    J Infect Chemother; 2022 Jul 17; 28(7):1008-1011. PubMed ID: 35428576
    [Abstract] [Full Text] [Related]

  • 38. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
    Inoue M, Ankou M, Hua J, Iwaki Y, Hagihara M, Ota Y.
    J Clin Exp Hematop; 2013 Jul 17; 53(1):95-9. PubMed ID: 23801140
    [Abstract] [Full Text] [Related]

  • 39. Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.
    Yamaga Y, Tokuyama K, Kato T, Yamada R, Murayama M, Ikeda T, Yamakita N, Kunieda T.
    Intern Med; 2016 Jul 17; 55(2):185-90. PubMed ID: 26781021
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.